Psychedelic drug developer Emyria says the use of MDMA (Molly, or Esstacy) has a lasting effect for post-traumatic stress disorder ...
Vous n'êtes pas connecté
A new study has found that small doses of liquid ketamine, taken in a clinical setting, can significantly reduce symptoms of post-traumatic stress disorder (PTSD) with fewer side effects. The study, conducted by researchers at the National PTSD Research Centre at the University of the Sunshine Coast (UniSC), was published in European Neuropsychopharmacology. It is the […]
Psychedelic drug developer Emyria says the use of MDMA (Molly, or Esstacy) has a lasting effect for post-traumatic stress disorder ...
A recent study has revealed that women have a significantly higher risk of developing long COVID compared to men, with women aged 40 to 55 being the...
A new review from the Cochrane Database of Systematic Reviews confirms that antidepressants can effectively reduce symptoms of generalized anxiety...
A group of scientists from the University of Auckland recently studied whether a cancer drug called alpelisib could also slow down aging. Alpelisib is...
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL...
In a ground-breaking study published in JAMA Network Open, researchers have found that exercise interventions significantly reduce depression and...
A new study from the University of Chicago Medicine reveals that people with alcohol use disorder (AUD) and depression experience high levels of...
New research presented at the European Congress on Obesity (ECO) in Venice, Italy, has found that poor muscle health can significantly increase the...
A new study has found that prescriptions for obesity medications are increasing, and this trend matches the rise in online searches for these drugs....
A recent study in the Food Science and Nutrition journal highlights lycopene, found in tomatoes and watermelons, as an effective and safer alternative...